How to more efficiently study complex treatment interactions
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
Study shows a link between obesity and what’s on local restaurant menus
MIT researchers analyzed the nutritional content of millions of menu items across Boston, London, and Dubai.
New postdoctoral fellowship program to accelerate innovation in health care
Launched with a gift from the Biswas Family Foundation, the Biswas Postdoctoral Fellowship Program will support postdocs in health and life sciences.
LLMs factor in unrelated information when recommending medical treatments
Researchers find nonclinical information in patient messages — like typos, extra white space, and colorful language — reduces the accuracy of an AI model.
MIT engineers uncover a surprising reason why tissues are flexible or rigid
Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.
Once-a-week pill for schizophrenia shows promise in clinical trials
The ingestible capsule forms a drug depot in the stomach, gradually releasing its payload and eliminating the need for patients to take medicine every day.
A high-fat diet sets off metabolic dysfunction in cells, leading to weight gain
Researchers also found these effects can be reversed by treatment with an antioxidant.
With AI, researchers predict the location of virtually any protein within a human cell
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
Study shows vision-language models can’t handle queries with negation words
Words like “no” and “not” can cause this popular class of AI models to fail unexpectedly in high-stakes settings, such as medical diagnosis.
Study of facial bacteria could lead to probiotics that promote healthy skin
During the early teen years, many new strains of C. acnes colonize the skin on our faces. This could be an optimal time for probiotic treatment.
Restoring healthy gene expression with programmable therapeutics
CAMP4 Therapeutics is targeting regulatory RNA, whose role in gene expression was first described by co-founder and MIT Professor Richard Young.
New method assesses and improves the reliability of radiologists’ diagnostic reports
The framework helps clinicians choose phrases that more accurately reflect the likelihood that certain conditions are present in X-rays.
MIT Solve announces 2025 Global Challenges
Leading social impact platform seeks tech innovators tackling global challenges in climate, health, learning, economic prosperity, and more.
MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
Is this the new playbook for curing rare childhood diseases?
When his son received a devastating diagnosis, Fernando Goldsztein MBA ’03 founded an initiative to help him and others.